当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第18期
编号:185905
血清DCP、CHI3L1联合AFP检测在肝细胞癌早期诊断中的意义研究
http://www.100md.com 2021年3月27日 中国医学创新 2021年第18期
     吕桂芳 张春 林建源 林枫 张代场

    【关键词】 脱-γ-羧基凝血酶原 壳多糖酶3样蛋白1 甲胎蛋白 肝细胞癌

    [Abstract] Objective: To investigate the significance of the combined detection of serum dec-γ-carboxylic prothrombin (DCP), chitosan enzyme 3-like protein 1 (CHI3L1) and alpha-fetoprotein (AFP) on improving the early diagnosis of hepatocellular carcinoma. Method: A total of 30 patients with early hepatocellular carcinoma admitted to our hospital from June 2014 to May 2016 were selected as hepatocellular carcinoma group, and 30 patients with hepatitis B cirrhosis were selected as cirrhosis group. During the same period, 30 healthy subjects who came to our hospital for physical examination were selected as healthy control group. AFP content was detected by electrochemiluminescence assay, DCP and CHI3L1 content were detected by enzyme linked immunosorbent assay, the above indicators among three groups were compared. Result: Serum DCP ......

您现在查看是摘要页,全文长 10474 字符